Phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
Morath C, Schmitt A, Kleist C, Daniel V, Opelz G, Süsal C, Ibrahim E, Kälble F, Speer C, Nusshag C, Pego da Silva L, Sommerer C, Wang L, Ni M, Hückelhoven-Krauss A, Czock D, Merle U, Mehrabi A, Sander A, Hackbusch M, Eckert C, Waldherr R, Schnitzler P, Müller-Tidow C, Hoheisel JD, Mustafa SA, Alhamdani MS, Bauer AS, Reiser J, Zeier M, Schmitt M, Schaier M, Terness P.
Morath C, et al. Among authors: alhamdani ms.
J Clin Invest. 2020 May 1;130(5):2364-2376. doi: 10.1172/JCI133595.
J Clin Invest. 2020.
PMID: 31990685
Free PMC article.
Clinical Trial.